Back to search

Article

FHL1 as a prognostic biomarker and therapeutic target in acute myeloid leukemia

2023-05-11

Abstract excerpt

Acute myeloid leukemia (AML) has a poor prognosis and high heterogeneity. Most leukemias are caused by environmental factors interacting with the cell’s genetic material, but treatment is still dominated by cell cycle drugs. Therefore, there is an urgent need to find reliable biomarkers. Based on the Gene Expression Omnibus database, Kaplan–Meier survival analysis and univariate Cox regression analysis were used t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99a3dfa6-1491-5659-a377-aa48e3dfbfea
DOI
10.21203/rs.3.rs-2854959/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FHL1 as a prognostic biomarker and therapeutic target in acute myeloid leukemiaDOI 10.21203/rs.3.rs-2854959/v1
Select a neighboring publication to make it the new centre.